367 related articles for article (PubMed ID: 10922301)
21. Improved antifungal polyene macrolides via engineering of the nystatin biosynthetic genes in Streptomyces noursei.
Brautaset T; Sletta H; Nedal A; Borgos SE; Degnes KF; Bakke I; Volokhan O; Sekurova ON; Treshalin ID; Mirchink EP; Dikiy A; Ellingsen TE; Zotchev SB
Chem Biol; 2008 Nov; 15(11):1198-206. PubMed ID: 19022180
[TBL] [Abstract][Full Text] [Related]
22. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4.
Bellocchio S; Gaziano R; Bozza S; Rossi G; Montagnoli C; Perruccio K; Calvitti M; Pitzurra L; Romani L
J Antimicrob Chemother; 2005 Feb; 55(2):214-22. PubMed ID: 15649994
[TBL] [Abstract][Full Text] [Related]
23. Changes in free and esterified cholesterol: hallmarks of acute renal tubular injury and acquired cytoresistance.
Zager RA; Kalhorn TF
Am J Pathol; 2000 Sep; 157(3):1007-16. PubMed ID: 10980139
[TBL] [Abstract][Full Text] [Related]
24. Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures.
Krause HJ; Juliano RL
Mol Pharmacol; 1988 Sep; 34(3):286-97. PubMed ID: 3419424
[TBL] [Abstract][Full Text] [Related]
25. Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure.
Zager RA; Iwata M; Conrad DS; Burkhart KM; Igarashi Y
Kidney Int; 1997 Jul; 52(1):60-70. PubMed ID: 9211347
[TBL] [Abstract][Full Text] [Related]
26. Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole.
Oakley KL; Moore CB; Denning DW
Antimicrob Agents Chemother; 1999 May; 43(5):1264-6. PubMed ID: 10223948
[TBL] [Abstract][Full Text] [Related]
27. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
[TBL] [Abstract][Full Text] [Related]
28. [Prostaglandin synthetase activity in the different layers of the kidneys of young rats exposed to polyene antibiotics].
Efendiev AM; Pomoĭnetskiĭ VD; Kubatiev AA
Biull Eksp Biol Med; 1986 Mar; 101(3):302-4. PubMed ID: 3082383
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of the selective toxicity of amphotericin B incorporated into liposomes.
Juliano RL; Grant CW; Barber KR; Kalp MA
Mol Pharmacol; 1987 Jan; 31(1):1-11. PubMed ID: 3807887
[TBL] [Abstract][Full Text] [Related]
30. S-[(1 and 2)-phenyl-2-hydroxyethyl]-cysteine-induced cytotoxicity to rat renal proximal tubules.
Chakrabarti SK; Denniel C
Toxicol Appl Pharmacol; 1996 Apr; 137(2):285-94. PubMed ID: 8661354
[TBL] [Abstract][Full Text] [Related]
31. Lipid-based antifungal agents: a concise overview.
Arikan S
Cell Mol Biol Lett; 2002; 7(3):919-22. PubMed ID: 12378276
[TBL] [Abstract][Full Text] [Related]
32. Antifungals and renal safety--getting the balance right.
Saliba F
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():21-4. PubMed ID: 16704922
[TBL] [Abstract][Full Text] [Related]
33. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity.
Zager RA; Johnson AC; Hanson SY
Kidney Int; 2003 Jul; 64(1):128-39. PubMed ID: 12787403
[TBL] [Abstract][Full Text] [Related]
34. Parenteral iron nephrotoxicity: potential mechanisms and consequences.
Zager RA; Johnson AC; Hanson SY
Kidney Int; 2004 Jul; 66(1):144-56. PubMed ID: 15200421
[TBL] [Abstract][Full Text] [Related]
35. Phospholipase A2: a potentially important determinant of adenosine triphosphate levels during hypoxic-reoxygenation tubular injury.
Zager RA; Conrad DS; Burkhart K
J Am Soc Nephrol; 1996 Nov; 7(11):2327-39. PubMed ID: 8959622
[TBL] [Abstract][Full Text] [Related]
36. Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells.
Wegner B; Baer P; Gauer S; Oremek G; Hauser IA; Geiger H
Nephrol Dial Transplant; 2005 Oct; 20(10):2071-9. PubMed ID: 15998654
[TBL] [Abstract][Full Text] [Related]
37. Interaction of amphotericin B and nystatin with phospholipid bilayer membranes:effect of cholesterol.
Singer MA
Can J Physiol Pharmacol; 1975 Dec; 53(6):1072-9. PubMed ID: 1222377
[TBL] [Abstract][Full Text] [Related]
38. Selective membrane toxicity of the polyene antibiotics: studies on lecithin membrane models (liposomes).
Hsuchen CC; Feingold DS
Antimicrob Agents Chemother; 1973 Sep; 4(3):309-15. PubMed ID: 4758835
[TBL] [Abstract][Full Text] [Related]
39. Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.
Johnson EM; Ojwang JO; Szekely A; Wallace TL; Warnock DW
Antimicrob Agents Chemother; 1998 Jun; 42(6):1412-6. PubMed ID: 9624486
[TBL] [Abstract][Full Text] [Related]
40. Molecular Umbrellas Modulate the Selective Toxicity of Polyene Macrolide Antifungals.
Skwarecki AS; Skarbek K; Martynow D; Serocki M; Bylińska I; Milewska MJ; Milewski S
Bioconjug Chem; 2018 Apr; 29(4):1454-1465. PubMed ID: 29485855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
